<p>Subject age, which was relatively normally distributed, is shown as mean±SD, together with age range. Gender is summarized as the percentage of male subjects in each group. Data for disease duration and Parkinson rating scales are presented as median and range because of the skewed nature of their distributions. Statistical comparisons relating to disease duration and Parkinson's disability scales were performed only between PD and APS patients. (RBD = rapid eye movement sleep behavior disorder; APS = atypical Parkinson syndromes; PD = typical Parkinson’s disease; CTL = clinically normal controls; UPDRS = Unified Parkinson’s Disease Rating Scale; NA = not applicable;</p>a<p>p<0.05 vs. subjects with PD).</p
BACKGROUND: Identifying factors influencing phenotypic heterogeneity in Parkinson's Disease is cruci...
<p>UPDRS = Unified Parkinson's Disease Rating Scale; LEU = L-dopa equivalent units; DA = dopamine ag...
<p>Demographic and clinical characteristics of cognitively normal PD patients (PD-CN) and cognitivel...
<p>Data are presented as mean, standard deviation, number and percentage.</p><p><b>HADS</b>: Hospita...
<p>Mean (standard deviation). p values were determined in t-tests (except for the gender ratio, to w...
<p>Data are presented with median (range) and frequency. Statistical comparisons were performed with...
<p>Mean values are provided with standard deviations denoted in parentheses. PD patients were observ...
<p>Demographic and neuropsychological data (mean ± standard deviation) for the Parkinson's disease p...
<p>p values were determined in t-tests (except for the gender ratio, for which a χ<sup>2</sup> test ...
<p>Data are presented as minimum - maximum (mean ± SD). PD, Parkinson's disease; NC, normal control;...
<p>UPDRS = unified Parkinson's disease rating score; H&Y = Hoehn and Yahr score; MMSE = mini m...
<p>PD = Parkinson's disease; ET = Essential Tremor; R = Right; L = Left; STN = subthalamic nucleus; ...
<p>BMI: body mass index, DA: dopamine agonist.</p><p>All continuous values were expressed as mean ± ...
<p>Demographic and clinical information of PPMI participants. Abbreviations: CI = 95% confidence int...
(1)<p>after adjustment for body mass index; Continuous variables are expressed by mean ± standard de...
BACKGROUND: Identifying factors influencing phenotypic heterogeneity in Parkinson's Disease is cruci...
<p>UPDRS = Unified Parkinson's Disease Rating Scale; LEU = L-dopa equivalent units; DA = dopamine ag...
<p>Demographic and clinical characteristics of cognitively normal PD patients (PD-CN) and cognitivel...
<p>Data are presented as mean, standard deviation, number and percentage.</p><p><b>HADS</b>: Hospita...
<p>Mean (standard deviation). p values were determined in t-tests (except for the gender ratio, to w...
<p>Data are presented with median (range) and frequency. Statistical comparisons were performed with...
<p>Mean values are provided with standard deviations denoted in parentheses. PD patients were observ...
<p>Demographic and neuropsychological data (mean ± standard deviation) for the Parkinson's disease p...
<p>p values were determined in t-tests (except for the gender ratio, for which a χ<sup>2</sup> test ...
<p>Data are presented as minimum - maximum (mean ± SD). PD, Parkinson's disease; NC, normal control;...
<p>UPDRS = unified Parkinson's disease rating score; H&Y = Hoehn and Yahr score; MMSE = mini m...
<p>PD = Parkinson's disease; ET = Essential Tremor; R = Right; L = Left; STN = subthalamic nucleus; ...
<p>BMI: body mass index, DA: dopamine agonist.</p><p>All continuous values were expressed as mean ± ...
<p>Demographic and clinical information of PPMI participants. Abbreviations: CI = 95% confidence int...
(1)<p>after adjustment for body mass index; Continuous variables are expressed by mean ± standard de...
BACKGROUND: Identifying factors influencing phenotypic heterogeneity in Parkinson's Disease is cruci...
<p>UPDRS = Unified Parkinson's Disease Rating Scale; LEU = L-dopa equivalent units; DA = dopamine ag...
<p>Demographic and clinical characteristics of cognitively normal PD patients (PD-CN) and cognitivel...